Business Description
Hemogenyx Pharmaceuticals PLC
ISIN : GB00BYX3WZ24
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | -0.66 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -6.3 | |||||
3-Year FCF Growth Rate | -6.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -92.25 | |||||
12-1 Month Momentum % | -92.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.38 | |||||
Quick Ratio | 4.38 | |||||
Cash Ratio | 2.91 | |||||
Days Payable | 73.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.4 | |||||
Shareholder Yield % | -19.41 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -162.87 | |||||
ROA % | -79.96 | |||||
ROIC % | -91.47 | |||||
ROC (Joel Greenblatt) % | -135.18 | |||||
ROCE % | -84.11 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 7.4 | |||||
EV-to-EBIT | -4.29 | |||||
EV-to-EBITDA | -4.94 | |||||
EV-to-FCF | -4.18 | |||||
Earnings Yield (Greenblatt) % | -23.31 | |||||
FCF Yield % | -25.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HOPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hemogenyx Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.007 | ||
Beta | 2.81 | ||
Volatility % | 97.19 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000076 | ||
20-Day SMA ($) | 0.0031 | ||
12-1 Month Momentum % | -92.25 | ||
52-Week Range ($) | 0.0031 - 0.04 | ||
Shares Outstanding (Mil) | 1,341.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hemogenyx Pharmaceuticals PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hemogenyx Pharmaceuticals PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Hemogenyx Pharmaceuticals PLC Frequently Asked Questions
What is Hemogenyx Pharmaceuticals PLC(HOPHF)'s stock price today?
When is next earnings date of Hemogenyx Pharmaceuticals PLC(HOPHF)?
Does Hemogenyx Pharmaceuticals PLC(HOPHF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |